LEADER 00818nam0-22003011i-450- 001 990006544730403321 005 20001010 035 $a000654473 035 $aFED01000654473 035 $a(Aleph)000654473FED01 035 $a000654473 100 $a20001010d--------km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $a<>origini dell'eta moderna$fErnst Hinrichs 205 $a5. ed. 210 $aRoma-Bari$cLaterza$d1992. 215 $aXVI, 270 p.$d21 cm 225 1 $aBiblioteca universale Laterza$v122 700 1$aHinrichs,$bErnst$0139792 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990006544730403321 952 $aCOLLEZ. 792 (122)$b17279$fFSPBC 959 $aFSPBC 996 $aOrigini dell'eta moderna$9619298 997 $aUNINA DB $aGEN01 LEADER 01144cam0-22003611i-450- 001 990006208200403321 005 20141110123843.0 035 $a000620820 035 $aFED01000620820 035 $a(Aleph)000620820FED01 035 $a000620820 100 $a20000112d1974----km-y0itay50------ba 101 1 $aita$cfre 102 $aIT 105 $ay-------001yy 200 1 $a<>sistema mondiale della droga$ela tossicomania come prodotto del capitalismo internazionale$fCatherine Lamour, Michel R. Lamberti$gtraduzione di Roberto Long 205 $a2. ed. 210 $aTorino$cEinaudi$dc1974 215 $a307 p.$d18 cm 225 1 $aNuovo politecnico$v61 454 0$12001$a<> grandes manoeuvres de l'opium$926911 676 $a363.4$v20$zita 700 1$aLamour,$bCatherine$0235114 701 1$aLamberti,$bMichel R.$0235115 702 1$aLong,$bRoberto 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990006208200403321 952 $aXV D 394 (61)$b19689*$fFGBC 952 $aXV D 394 (61 BIS)$b106474$fFGBC 959 $aFGBC 996 $aGrandes manoeuvres de l'opium$926911 997 $aUNINA LEADER 05201oam 2200685I 450 001 9910781032903321 005 20230725045100.0 010 $a0-429-06600-7 010 $a1-282-56095-6 010 $a9786612560958 010 $a1-84184-746-1 024 7 $a10.3109/9781841847467 035 $a(CKB)2550000000012398 035 $a(EBL)1407502 035 $a(SSID)ssj0000422904 035 $a(PQKBManifestationID)11291568 035 $a(PQKBTitleCode)TC0000422904 035 $a(PQKBWorkID)10432027 035 $a(PQKB)11169057 035 $a(MiAaPQ)EBC1407502 035 $a(MiAaPQ)EBC516894 035 $a(Au-PeEL)EBL1407502 035 $a(CaPaEBR)ebr10384016 035 $a(CaONFJC)MIL256095 035 $a(OCoLC)899155670 035 $a(OCoLC)649900583 035 $a(Au-PeEL)EBL516894 035 $a(EXLCZ)992550000000012398 100 $a20180331d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aMechanical reperfusion for STEMI $efrom randomized trials to clinical practice /$fedited by Giuseppe De Luca, Alexandra Lansky 210 1$aNew York :$cInforma Healthcare,$d2010. 215 $a1 online resource (310 p.) 300 $aDescription based upon print version of record. 311 $a1-84184-696-1 320 $aIncludes bibliographical references and index. 327 $aFront Cover; Foreword; Preface; Contents; Chapter 1. Primary Angioplasty Vs. Fibrinolysis: An Overview of Randomized Trials and Registry Data; Chapter 2. Which Patients Should Be Transferred for Primary PCI?; Chapter 3. Pharmacological Facilitation in Primary Angioplasty: Myth or Reality? ; Chapter 4. How to Organize Hetworks for Invasive Treatment of STEMI: Krakow Experience; Chapter 4a. How to Organize Networks for Invasive Treatment of STEMI: Krakow Experience; Chapter 4b. How to Organize Networks for INvasive Treatment of STEMI: THe Zwolle Experience 327 $aChapter 4c. How to Organize Networks for Invasive Treatment of STEMI: Link ?oping ExperienceChapter 4d. How to Organize Networks for Invasive Treatment of STEMI: Experience in the United States; Chapter 4e. How to Organize Networks for Invasive Treatment of STEMI: Experience in Asia; Chapter 5: Failed Thrombolysis: Rescue Angioplasty or Conservative Therapy?; Chapter6. Primary PCI in Cardiogenic Shock and Out-of-Hospital Cardiac Arrest; Chapter 7. Oral Antiplatelet Therapy; Chapter 8. Glycoprotein IIb/IIIa Inhibitors; Chapter 9. Anticoagulation Therapy; Chapter 10. Balloon Angioplasty or BMS? 327 $aChapter 11. Drug-Eluting Stent: Weighing Costs and BenefitsChapter 12. Mechanical Prevention of Distal Embolization; Chapter 13. Distal Protection Devices: Tips and Tricks; Chapter 14. Thrombectomy Devices: Tips and Tricks; Chapter 15. Proximal Devices: Tips and Tricks; Chapter 16. Hemodynamic Support in High-Risk Patients; Chapter 17. Limitation of Infarct Size: Ajunctive Mechanical Devices; Chapter 18. Transradial Access for Primary PCI: Advantages beyond any Doubt; Chapter 19. Intravascular Imaging: IVUS, OCT, and Angioscopy 327 $aChapter 20. Redefining the Success of Mechanical Reperfusion: ST-Segment ResolutionChapter 21. Redefining the Success of Mechanical Reperfusion: TIMI Flow and Myocardial Blush; Chapter 22. Redifining the Success of Mechanical Reperfusion: Doppler Flow-Wire; Chapter 23. Redifining the Success of Mechanical Reperfusion: Cardiac MRI; Chapter 24. Redefining the Success of Mechanical Reperfusion: Contrast Echocardiography; Chapter 25. Redifining the Success of Mechanical Reperfusion 327 $aChapter 26. Bleeding Complications in Patients Undergowing Percutaneous Coronary Intervention: Prognostic Implications and PreventionChapter 27. Contrast-Induced Nephropathy in Patients Undergoing Primary Angioplasty: Prognostic Implications, Prevention, and Management; Chapter 28. Myocardial Regeneration: Cell-Therapy After Reperfusion in Patients with ST-Elevation Myocardial Infarction; Chapter 29. Early Discharge After Primary PCI; Chapter 30. ACC/AHA and ESC Guidelines; Index; Back Cover 330 $a

As a leading cause of death in developed countries, ST-segment elevation myocardial infarction and its various treatment options are of great concern to those in the cardiology field. This text presents evidence-based chapters that supply clinicians with real-life situations and strategies to treat STEMI patients more effectively and at a quicker pace. A highly illustrated and fully referenced source, this comprehensive text provides both a scientific background and a practical overview of the invasive management of STEMI patients.

606 $aMyocardial infarction$xTreatment 606 $aMyocardial reperfusion 615 0$aMyocardial infarction$xTreatment. 615 0$aMyocardial reperfusion. 676 $a616.1/24 701 $aDe Luca$b Giuseppe$f1974-$01516574 701 $aLansky$b Alexandra$01516575 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910781032903321 996 $aMechanical reperfusion for STEMI$93753135 997 $aUNINA